
    
      Eligibility for participation of this study will be determined from demographic information,
      medical history, physical examination, electrocardiogram (ECG) and clinical laboratory tests
      within 4 weeks before study drug administration. Subjects suitable for this study will be
      admitted to the Clinical Trial Center of Ajou University Medical Center on the day before
      dosing (Day -1).

      On Day 1, Subjects will be dosed simvastatin 40 mg or pravastatin 20 mg. Pharmacokinetic
      samplings and blood pressure/pulse rate measurement will be done upto 24 hours after dosing.

      From Day 2 ~ 7, Subjects will be dosed cilostazol 100 mg twice a day. On Day 8, Subjects will
      be dosed simvastatin 40 mg or pravastatin 20 mg with cilostazol 100 mg twice a day.
      Pharmacokinetic samplings and blood pressure/pulse rate measurement will be done upto 24
      hours after dosing.
    
  